| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.32 | 0.04 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.32 | 0.04 |